What's New

Last Posted: May 11, 2023

• Lung clearance index in children with cystic fibrosis previously diagnosed with CRMS/CFSPID: A monocentric prospective experience.
  Vito Terlizzi et al. Pediatr Pulmonol 2023
• Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosis.
  Yeva Sahakyan et al. J Cyst Fibros 2023
• Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators.
  Vito Terlizzi et al. Int J Mol Sci 2023 24(7)
• Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.
  Edmund H Sears et al. Annals of the American Thoracic Society 2023
• Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
  Mohini A Gunnett et al. Frontiers in pediatrics 2023 111127659
• Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor.
  Payal Patel et al. International journal of neonatal screening 2023 9(1)
• Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020.
  Elizabeth A Cromwell et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2023
• Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis.
  Kevin W Southern et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2023 22(1) 17-30
• Sweat conductivity for diagnosing cystic fibrosis after positive newborn screening: prospective, diagnostic test accuracy study.
  Renata Marcos Bedran et al. Archives of disease in childhood 2023
• Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing.
  Tatiana N Yuzyuk et al. Critical reviews in clinical laboratory sciences 2023 1-16
• Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
  Louise J Geneen et al. The Cochrane database of systematic reviews 2023 3(3) CD012349
• Early life growth trajectories in cystic fibrosis are associated with lung function at age six.
  Kevin J Psoter et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2023
• Incidence of transaminitis in adults with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor.
  Marci Wood et al. Journal of the American Pharmacists Association : JAPhA 2023
• A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening.
  Antonella Tosco et al. Children (Basel, Switzerland) 2023 10(2)
• CFTR-Related Metabolic Syndrome: Genetic Variants Increasing Pancreatitis Risk in the Pediatric Puerto Rican Population.
  Jesús M Meléndez-Montañez et al. Children (Basel, Switzerland) 2023 10(2)
• Cystic Fibrosis: A Descriptive Analysis of Deaths in a Two-Decade Period in Brazil According to Age, Race, and Sex.
  Luan Victor Frota de Azevedo et al. Diagnostics (Basel, Switzerland) 2023 13(4)
• External validity of machine learning-based prognostic scores for cystic fibrosis: A retrospective study using the UK and Canadian registries.
  Yuchao Qin et al. PLOS digital health 2023 2(1) e0000179
• Economic evaluation of population-based expanded reproductive carrier screening for genetic diseases in Australia.
  Deborah Schofield et al. Genetics in medicine : official journal of the American College of Medical Genetics 2023 100813
• Lower Expression of CFTR Is Associated with Higher Mortality in a Meta-Analysis of Individuals with Colorectal Cancer.
  Patricia Scott et al. Cancers 2023 15(3)
• Future therapies for cystic fibrosis.
  Lucy Allen et al. Nature communications 2023 14(1) 693

More